INTANGIBLE ASSETS, NET (Details) - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets
Accumulated Amortization	$ (200,626)	$ (146,081)
Indefinite-Lived Intangible Assets
Gross Carrying Amount	2,606,598	1,761,332
Net Amount	2,405,972	1,615,251
Hormone Therapy Drug Candidate Patents - (Pending) [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	1,203,987	774,165
Net Amount	1,203,987	774,165
Multiple Trademarks For Vitamins/Supplements [Member]
Indefinite-Lived Intangible Assets
Gross Carrying Amount	185,465	157,721
Net Amount	185,465	157,721
Opera Software Patent [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	31,951	31,951
Accumulated Amortization	(6,490)	(4,493)
Net Amount	$ 25,461	$ 27,458
Weighted average remaining amortization period	12 years 9 months	13 years 9 months
Development Costs Of Corporate Website [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 91,743	$ 91,743
Accumulated Amortization	(91,743)	(91,743)
Approved Hormone Therapy Drug Candidate Patents [Member]
Finite-Lived Intangible Assets
Gross Carrying Amount	1,093,452	705,752
Accumulated Amortization	(102,393)	(49,845)
Net Amount	$ 991,059	$ 655,907
Weighted average remaining amortization period	16 years	17 years